Back to Search
Start Over
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study
- Source :
- Clinical Genitourinary Cancer; 20220101, Issue: Preprints
- Publication Year :
- 2022
-
Abstract
- Considerable numbers of patients with metastatic urothelial carcinoma (mUC) develop bone metastases (BoM). Their impact on the efficacy of immune-checkpoint inhibitors (ICIs) is not yet investigated.
Details
- Language :
- English
- ISSN :
- 15587673
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- Clinical Genitourinary Cancer
- Publication Type :
- Periodical
- Accession number :
- ejs58496400
- Full Text :
- https://doi.org/10.1016/j.clgc.2021.12.008